Amantadine Hydrochloride Capsule
Product Images NDC 68382-512

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Amantadine Hydrochloride (NDC 68382-512). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals (usa) Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

05df557a 34f5 43bb B988 5a8f8d84b898 01

05df557a 34f5 43bb B988 5a8f8d84b898 01
This is not enough information to generate a description. "NH HCI" may refer to a chemical compound or abbreviation for a medical term, but without context, it is not possible to determine.*
FDA Label Image

05df557a 34f5 43bb B988 5a8f8d84b898 02

05df557a 34f5 43bb B988 5a8f8d84b898 02
This is a medication label for Amantadine Hydrochloride capsules. The hard gelatin capsules are used as per the usual dosage indicated in the package insert. The medication must be stored in a tight container at a temperature between 20°C to 25°C. The manufacturer of the product is Cadila Healthcare Ltd., located in Ahmedabad, India. The product is packaged and distributed by Zydus Pharmaceuticals (USA) Inc., of Pennington, NJ, and is only available through prescription.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.